A First in Class, Open-Label, First-in-Human, Phase I Trial of Daily Oral Pclx-001

被引：0

作者：

Sangha, Randeep ^{[1
]}

Sehn, Laurie H. ^{[2
,3
]}

Jamal, Rahima ^{[4
]}

Spratlin, Jennifer ^{[5
]}

Kuruvilla, John ^{[6
]}

Weickert, Michael J. ^{[7
]}

Berthiaume, Luc G. ^{[8
]}

Mackey, John R. ^{[1
,5
]}

机构：

[1] Univ Alberta, Dept Oncol, Edmonton, AB, Canada

[2] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada

[3] Univ British Columbia, Vancouver, BC, Canada

[4] Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Axe Canc, Div Hematooncol, Montreal, PQ, Canada

[5] Cross Canc Inst, Edmonton, AB, Canada

[6] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[7] Pacylex Pharmaceut Inc, Edmonton, AB, Canada

[8] Univ Alberta, Edmonton, AB, Canada

来源：

关键词：

D O I：

10.1182/blood-2022-168140

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：12057 / 12058

页数：2